DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹2,113 Cr | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹2,113 Cr |
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹778 Cr |
| Mar2023 | ₹212 Cr |
| Mar2022 | ₹470 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,113 Cr | 106.75 | |
| Mar2025 | ₹1,022 Cr | 31.36 | |
| Mar2024 | ₹778 Cr | 266.98 | |
| Mar2023 | ₹212 Cr | -54.89 | |
| Mar2022 | ₹470 Cr | - | |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹253,419.8 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| MANKIND PHARMA | ₹102,650.0 Cr | -2.4% | 6% | 0.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.7% |
3.2% |
61.7% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses